Ginkgo Bioworks
27 Drydock Avenue
8th Floor
Boston
Massachusetts
02210
United States
Tel: 814-HACK-DNA
Website: http://ginkgobioworks.com/
265 articles about Ginkgo Bioworks
-
Ginkgo Bioworks Reports Third Quarter 2021 Results
11/15/2021
Ginkgo Bioworks Holdings, Inc., the leading horizontal platform for cell programming, announced its results for the third quarter ended September 30, 2021.
-
Ginkgo Bioworks Launches Cell Development Kit Service for Standardized, Low-Cost Entry to its Cell Programming Platform
11/11/2021
Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the launch of its Cell Development Kits service.
-
Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria
11/9/2021
Synlogic, Inc., a clinical-stage company bringing the transformative potential of synthetic biology to medicine, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the nomination of SYNB1353, an investigational Synthetic BioticTM medicine for the treatment of homocystinuria.
-
Ginkgo Bioworks Announces Date of Third Quarter 2021 Results Presentation
11/8/2021
Ginkgo Bioworks, the leading horizontal platform for cell programming, announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2021, on Monday, November 15, 2021, beginning at 8:00 a.m. ET.
-
Many mergers took place in 2021. Here’s a look at some of the hottest life sciences SPAC merger announcements so far in 2021. Many mergers took place in 2021,
-
Ginkgo Bioworks Previews Today's Annual Ferment Conference
10/28/2021
Ginkgo Bioworks, the leading horizontal platform for cell programming, is hosting its annual conference Ferment.
-
Ginkgo Bioworks Announces Participation in Jefferies Gene Therapy/Editing Summit
10/20/2021
Ginkgo Bioworks Inc. announced today that management is scheduled to present at the Jefferies Gene Therapy/Editing Summit on Wednesday, October 27, 2021 at 3:00p.m. Eastern Time .
-
Litigator Block & Leviton is launching an investigation into Ginkgo Bioworks after short seller Scorpion Capital released a report alleging that Ginkgo is running a fraudulent operation.
-
Wanting to find out what is fueling the trend, BioSpace solicited the perspectives of a couple of executives who chose the SPAC route.
-
Students, Venture Capitalists Launch Equity-Free Program To Support Future Biotech Leaders
9/28/2021
Nucleate, the non-profit organization seeking to support future leaders in the life sciences industry, announced its official launch and immediately opened applications to its Activator program. -
Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds
9/17/2021
Ginkgo Bioworks, Inc. and Soaring Eagle Acquisition Corp., a special purpose acquisition company, announced the closing of their previously announced business combination.
-
Tantu and Ginkgo Bioworks Announce Partnership to Engineer a Living Biotherapeutic for Gastrointestinal Healing
9/7/2021
Tantu, a company engineering living biotherapeutic products to treat gastrointestinal diseases, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, announced a partnership to accelerate the research and development of Tantu's therapeutic genes.
-
Boston-based Ginkgo Bioworks has been having a banner year and doesn’t show any signs of stopping with its recent string of collaboration announcements.
-
Ginkgo Bioworks Announces Participation In Upcoming Virtual Conferences in September 2021
9/3/2021
Ginkgo Bioworks Inc., which is building the leading horizontal platform for cell programming and recently announced a business combination with Soaring Eagle Acquisition Corp., announced that management is scheduled to participate in the following upcoming conferences
-
Cambium Biomaterials Announces Partnership with Ginkgo Bioworks to Accelerate Industrial Adoption of High-Performance Biomaterials
9/2/2021
Cambium Biomaterials, the company creating high-performance biomaterials, announced a partnership with Ginkgo Bioworks, Inc., which is building the leading horizontal platform for cell programming.
-
Ginkgo Bioworks and Givaudan Enter Multi-Program Collaboration to Produce a Series of Ingredients
8/30/2021
Ginkgo Bioworks, Inc., which is building the leading horizontal platform for cell programming, announced the signing of a multi-program collaboration with Givaudan, the world's leading Taste & Wellbeing and Fragrance & Beauty company.
-
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
8/23/2021
Cronos Group, Inc. and Ginkgo Bioworks today announced the achievement of the first target productivity milestone in their partnership to produce eight cultured cannabinoids.
-
Ginkgo has signed multiple collaborations, announced a breakthrough in manufacturing mRNA vaccine components, and landed an SPAC deal.
-
Ginkgo Bioworks Provides First Half 2021 Update
8/18/2021
Ginkgo Bioworks today announced a revenue and business update for the first half of 2021.
-
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology
8/12/2021
Antheia and Ginkgo Bioworks today announced a partnership to accelerate the development and production of essential medicines.